• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝癌二级预防共识(2021年版)

[Consensus on secondary prevention of primary liver cancer (2021 version)].

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):216-226. doi: 10.3760/cma.j.cn501113-20210210-00082.

DOI:10.3760/cma.j.cn501113-20210210-00082
PMID:33902188
Abstract

In order to standardize the effective prevention, early screening and diagnosis of the population at risk of primary liver cancer, the Chinese Society of Hepatology and Chinese Medical Association organized the relevant domestic experts to formulate the "Consensus on Secondary Prevention of Primary Liver Cancer (2021 version)," based on the basic, clinical and preventive research progress, combined with the actual situation at home and abroad, so as to provide an important basis for the prevention, screening and early diagnosis of primary liver cancer in the population of chronic liver disease.

摘要

为规范原发性肝癌高危人群的有效预防、早期筛查及诊断,中华医学会肝病学分会和中华医学会组织国内相关专家,基于基础、临床及预防研究进展,并结合国内外实际情况,制定了《原发性肝癌二级预防共识(2021年版)》,以期为慢性肝病患者人群原发性肝癌的预防、筛查及早期诊断提供重要依据。

相似文献

1
[Consensus on secondary prevention of primary liver cancer (2021 version)].原发性肝癌二级预防共识(2021年版)
Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):216-226. doi: 10.3760/cma.j.cn501113-20210210-00082.
2
Consensus on the secondary prevention of primary liver cancer.原发性肝癌二级预防共识。
Hepatol Int. 2021 Dec;15(6):1289-1300. doi: 10.1007/s12072-021-10259-7. Epub 2021 Nov 30.
3
Consensus on the tertiary prevention of primary liver cancer.原发性肝癌三级预防共识。
Hepatol Int. 2023 Oct;17(5):1057-1071. doi: 10.1007/s12072-023-10549-2. Epub 2023 Jun 27.
4
[The consensus on tertiary prevention of primary liver cancer (2022 version)].《原发性肝癌三级预防共识(2022年版)》
Zhonghua Gan Zang Bing Za Zhi. 2022 Aug 20;30(8):832-845. doi: 10.3760/cma.j.cn501113-20220616-00330.
5
Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.亚太地区肝细胞癌的预防:共识声明。
J Gastroenterol Hepatol. 2010 Apr;25(4):657-63. doi: 10.1111/j.1440-1746.2009.06167.x.
6
[Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)].肝细胞癌癌前病变诊断与治疗多学科专家共识(2023年版)
Zhonghua Gan Zang Bing Za Zhi. 2023 Dec 20;31(12):1250-1261. doi: 10.3760/cma.j.cn501113-20231010-00136.
7
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.日本肝细胞癌的管理:日本肝脏学会(JSH)2010 年更新版提出的基于共识的临床实践指南。
Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.
8
Prevention of hepatocellular carcinoma in chronic liver disease: molecular markers and clinical implications.慢性肝病中肝细胞癌的预防:分子标志物及临床意义
Dig Dis. 2001;19(4):338-44. doi: 10.1159/000050701.
9
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.肝癌管理共识指南:2016 年由台湾肝癌医学会和台湾消化系医学会更新。
J Formos Med Assoc. 2018 May;117(5):381-403. doi: 10.1016/j.jfma.2017.09.007. Epub 2017 Oct 24.
10
Screening for hepatocellular carcinoma in cirrhotic patients.肝硬化患者肝细胞癌的筛查
J Am Coll Radiol. 2008 Sep;5(9):1012-4. doi: 10.1016/j.jacr.2008.01.017.

引用本文的文献

1
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension.肝硬化门静脉高压症食管胃底静脉曲张出血的管理指南
J Clin Transl Hepatol. 2023 Dec 28;11(7):1565-1579. doi: 10.14218/JCTH.2023.00061. Epub 2023 Oct 17.
2
Chinese expert consensus statement on the clinical application of AFP/AFP-L3%/DCP using GALAD and GALAD-like algorithm in HCC.《基于 AFP/AFP-L3%/DCP 联合 GALAD 和 GALAD 算法在 HCC 临床应用的专家共识》
J Clin Lab Anal. 2023 Dec;37(23-24):e24990. doi: 10.1002/jcla.24990. Epub 2023 Dec 8.
3
Development and application of hepatocellular carcinoma risk prediction model based on clinical characteristics and liver related indexes.
基于临床特征和肝脏相关指标的肝细胞癌风险预测模型的建立与应用
World J Gastrointest Oncol. 2023 Aug 15;15(8):1486-1496. doi: 10.4251/wjgo.v15.i8.1486.